- Most orders ship within 48 hours from our facility in Aiken, SC
- All orders are FOB (we charge actual frieght) under $2000
- Free shipping on orders over $2000.
- Accepts VISA & MC, AmEx.
- No international orders.
- Large orders weighing over 150 lbs. will be shipped via freight on a pallet.
- Corta-Flx/ Manna Pro Products has unilaterally adopted this Minimum Advertised Price (MAP) Policy for select products. Please review and comply with our MAP policy.
We introduced our original Corta-Flx® First-Of-Its-Kind formulation to the Equine Industry nearly 15 years ago. After years of research, we developed the unique Corta-Flx® formulation of micro-sized isolates comparable to the key active ingredients found in Chondroitin and Glucosamine. Such small micro-sized isolates penetrate the horse's cellular walls more effciently than larger ones, thus providing quicker and more effective nourishment to affected joints. Corta-Flx® worked so well on the horses that were tested, that we guaranteed dramatic results in 5 days on the label. A competitor using the generic Chondroitin and Glucosamine ingredients in their products stated the "idea that a joint supplement can respond to treatment and heal in under 5 days is patently ridiculous." Our competitors product labeling and literature stated it may take weeks before you see any improvement at all. Some even had Corta-Flx® tested for MSM, phenylbutazone, and DMSO. Test results were negative for such ingredients. The Horse Journal tested Corta-Flx® and other joint products in the marketplace for comparable effectiveness. The Horse Journal said at the beginning of their testing they were also skeptical of our Guaranteed 5 Day Dramatic Results . After completion of product testing, The Horse Journal concluded and published that the dramatic results were achieved in only 3 days. The Horse Journal proclaimed Corta-Flx® as the Equine "Product Of The Year." Michigan State University performed a clinical double-blind placebo study proving Corta-Flx® isolates improved joint mobility in horses with degenerative joint disease (DJD).
Recently the original Corta-Flx® formulation was taken to a new level. The clinically-proven Corta-Flx® formulation of micro-sized isolates was enhanced with a vegetable-based source of 50 mg low molecular weight Hyaluronic Acid (LMW-HA) per serving. HA plays an important fundamental role in maintaining the fluid between the joints, providing the cushioning and lubrication necessary for pain-free movement.
For a complete review of the Corta- Flx® Research as it was presented to the Convention of the American Association of Equine Practitioners (AAEP) in Orlando, Florida, visit: www.jointsupplementresearch.com